Population scale data reveals the antidepressant effects of ketamine and other therapeutics approved for non-psychiatric indications
Abstract Current therapeutic approaches to depression fail for millions of patients due to lag in clinical response and non-adherence. Here we provide new support for the antidepressant effect of an anesthetic drug, ketamine, by Inverse-Frequency Analysis of eight million reports from the FDA Advers...
Saved in:
Main Authors: | Isaac V. Cohen, Tigran Makunts, Rabia Atayee, Ruben Abagyan |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2017
|
Subjects: | |
Online Access: | https://doaj.org/article/29cfb95bdea44b70a57ebcd61bd9f670 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Publisher Correction: Population scale data reveals the antidepressant effects of ketamine and other therapeutics approved for non-psychiatric indications
by: Isaac V. Cohen, et al.
Published: (2017) -
Targeting inflammation in depression: Ketamine as an anti-inflammatory antidepressant in psychiatric emergency
by: Naghmeh Nikkheslat
Published: (2021) -
Concomitant drugs associated with increased mortality for MDMA users reported in a drug safety surveillance database
by: Isaac V. Cohen, et al.
Published: (2021) -
Immunoregulation and antidepressant effect of ketamine
by: Zhang Nan, et al.
Published: (2021) -
The role of dissociation in ketamine’s antidepressant effects
by: Elizabeth D. Ballard, et al.
Published: (2020)